Insidertrades

Arrowhead Pharmaceuticals

ARWR

Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for Hepatitis B, the liver disease associated with alpha 1-antitryps …

© Wikipedia / Creative Commons CC-BY-SA 3.0 more at Wikipedia

Insider trades and stock quote 2024-2026

All insider trades at Arrowhead Pharmaceuticals

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/18/2026 Sell Olukotun, Adeoye Y. Director $87.0 $173,920
8/18/2026 Sell Perry, Michael S. Director $87.3 $1,012,680
5/12/2026 Sell Lu, Hongbo Director $76.9 $228,334
4/23/2026 Sell Hamilton, James C. Chief Medical Officer $75.0 $750,000
4/22/2026 Sell Apel, Daniel Joseph Chief Financial Officer $70.8 $934,286
3/5/2026 Sell Hamilton, James C. Chief Medical Officer $64.2 $641,900
1/5/2026 Sell O'brien, Patrick COO $63.9 $3,123,349
1/5/2026 Sell Hamilton, James C. Chief Medical Officer $64.1 $2,534,661
1/2/2026 Sell Anzalone, Christopher Richard Chief Executive Officer $66.1 $871,703
12/29/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $69.0 $3,575,575
12/26/2025 Sell Ferrari, Mauro Director $70.0 $527,100
12/22/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $68.6 $861,340
12/19/2025 Sell Olukotun, Adeoye Y. Director $67.7 $676,623
12/19/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $67.7 $909,682
12/19/2025 Sell Waddill, William D. Director $67.7 $566,039
12/19/2025 Sell Vakiener, Victoria Director $67.7 $679,491
12/17/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $65.0 $5,443,462
12/16/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $64.0 $3,398,186
12/15/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $69.3 $8,950,615
12/5/2025 Sell Perry, Michael S. Director $61.0 $991,738
11/28/2025 Sell Ferrari, Mauro Director $56.4 $493,413
10/1/2025 Sell Hamilton, James C. Chief Medical Officer $35.0 $700,000
9/12/2025 Sell Hamilton, James C. Chief Medical Officer $30.0 $450,000
9/2/2025 Sell Hamilton, James C. Chief Medical Officer $25.0 $375,000
8/15/2025 Sell Hamilton, James C. Chief Medical Officer $20.0 $187,780
8/13/2025 Sell Hamilton, James C. Chief Medical Officer $20.0 $12,220
4/11/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $11.5 $583,692
4/10/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $10.9 $543,500
4/9/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $10.8 $406,145
3/13/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $15.1 $774,975
3/4/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $17.0 $2,269,328
3/3/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $18.0 $3,005,006
1/23/2025 Sell Olukotun, Adeoye Y. Director $21.0 $20,139
1/7/2025 Sell Myszkowski, Kenneth Allen Chief Financial Officer $19.7 $354,500
1/7/2025 Sell O'brien, Patrick COO and General Counsel $19.7 $157,520
1/6/2025 Sell Myszkowski, Kenneth Allen Chief Financial Officer $19.9 $538,595
1/6/2025 Sell O'brien, Patrick COO and General Counsel $19.9 $578,539
1/6/2025 Sell Hamilton, James C. Chief Discovery/Trans Medicine $19.9 $648,824
1/2/2025 Sell Anzalone, Christopher Richard Chief Executive Officer $19.0 $219,456
12/27/2024 Sell Olukotun, Adeoye Y. Director $20.0 $57,000
12/23/2024 Sell Anzalone, Christopher Richard Chief Executive Officer $19.6 $246,109
12/18/2024 Sell Anzalone, Christopher Richard Chief Executive Officer $21.5 $567,486
12/17/2024 Sell Given, Douglas B. Director $22.0 $12,056
12/17/2024 Sell Waddill, William D. Director $22.0 $82,584
12/16/2024 Sell Vakiener, Victoria Director $21.9 $197,059
12/16/2024 Sell Given, Douglas B. Director $21.9 $109,500
12/16/2024 Sell Waddill, William D. Director $21.9 $82,081
Rows per page:
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)